Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $75.00 and last traded at $75.00, with a volume of 380 shares traded. The stock had previously closed at $71.20.
Analyst Upgrades and Downgrades
Separately, Chardan Capital upgraded Pharma Mar to a “strong-buy” rating in a research report on Thursday, August 1st.
Read Our Latest Report on Pharma Mar
Pharma Mar Price Performance
Pharma Mar Company Profile
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
See Also
- Five stocks we like better than Pharma Mar
- How Investors Can Find the Best Cheap Dividend Stocks
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What Are Growth Stocks and Investing in Them
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Election Stocks: How Elections Affect the Stock Market
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
